Clinical Trial Update: Omarigliptin (MK-3102) Clinical Trial - Add-on to Oral Antihyperglycemic Agent Study in Japanese Participants With Type 2 Diabetes Mellitus (MK-3102-015) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for Omarigliptin as add-on therapy to oral antihyperglycemic agents in Japanese patients with Type 2 Diabetes Mellitus (MK-3102-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Omarigliptin (omarigliptin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2015-10-29